Navigation Links
First Stem Cell Study for Peyronie's in Humans Shows Promise
Date:10/8/2015

CORAL SPRINGS, Fla., Oct. 8, 2015 /PRNewswire/ -- Unless you were living with it, it's likely you were unaware of male sexual dysfunction until the late 90's when pharmaceutical companies started huge campaigns for treatment of Erectile Dysfunction (ED).

Erectile Dysfunction isn't the only form of male sexual dysfunction. A condition called Peyronie's Disease has gone largely overlooked, and existing treatments haven't met with much success. Dr. Michael Zahalsky, a Florida urologist fellowship trained in male sexual dysfunction and pioneer in the use of biologics in Urology, is on a mission to help men affected by all male sexual dysfunction. As a result of his work, patients are experiencing groundbreaking success, thanks to the help of a trial using amniotic stem cells and growth factors.

Peyronie's Disease (PD) is characterized by the presence of fibrous plaque that causes an abnormal curvature of the penis during an erection. Often, this can make it difficult and painful to obtain or maintain an erection. It's been estimated that up to 7% of the male population is affected by PD. This week in The Journal of the American Osteopathic Association, Dr. Zahalsky published his groundbreaking results using amniotic stem cells and growth factors for Peyronie's Disease. He says his research on ED has already been accepted for publication in the same Journal.

"Patients who suffer from male sexual dysfunction suffer from so much more than the inability to perform," says Dr. Zahalsky. "They're generally unhappier, and can suffer from lack of confidence, depression, anxiety, sleeplessness and more. Because Peyronie's can affect young men, it can have a damaging effect on their overall happiness. We had to find a better way to treat this."

The most promising results of the study included the effect of the treatment on fibrous plaque material found in the penis: 7 of 10 fibrous plaques disappeared completely, all patients had an improvement in blood flow, and curvature of the penis dramatically improved.

"We believe this was the first ever study on the use of injectable stem cells to manage Peyronie's Disease in humans," says Dr. Zahalsky. "We're thrilled with the early results from the study, and look forward to continuing research on this evolving field of urologic biologics."

Contact: Dr. Michael Zahalsky, 954-714-8200, DrZ@Zurology.com  


'/>"/>
SOURCE Zurology
Copyright©2015 PR Newswire.
All rights reserved

Related medicine technology :

1. Pharmagen Announces First Quarter 2013 Results
2. Vasomedical Announces Financial Results for the First Quarter of 2013
3. SOAPware President Randall Oates, M.D. Among First NCQA Certified Patient-Centered Medical Home Content Experts
4. Access Pharmaceuticals Reports First Quarter Results
5. ULURU Inc. Reports First Quarter 2013 Financial Results
6. A*STAR and Cytos Bring Singapores First Influenza Vaccine to Clinical Testing
7. Sinovac to Host Conference Call to Report First Quarter 2013 Unaudited Financial Results
8. ConvaTec Announces 2013 First Quarter Earnings Call
9. Claret Medical, Inc. Announces Publication of the First Clinical Research on the Frequency and Composition of Embolic Debris Captured during TAVR
10. Concord Medical Reports First Quarter 2013 Financial Results
11. Medifirst Solutions, Inc. Announces Update To Shareholders
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/11/2017)... , Oct. 11, 2017  Caris Life Sciences ® ... fulfilling the promise of precision medicine, today announced that ... Caris, Precision Oncology Alliance™ (POA) as its 17 th ... the St. Jude Crosson Cancer Institute will help develop ... use of tumor profiling, making cancer treatment more precise ...
(Date:10/10/2017)... ORANGE COUNTY, Calif. , Oct. 10, 2017  NDS received ... Mobile  — a medical-grade battery-powered display stand specifically designed for ... aims to transform technology into a clinical solution to support the ... costs. Innovative Design ... NDS ZeroWire Mobile Wireless Solution ...
(Date:10/5/2017)... Oct. 5, 2017  In response to the ... and Maxillofacial Surgeons (AAOMS) released prescribing recommendations that ... be used as a first-line therapy to manage ... Recognizing the value and ... Paper "Opioid Prescribing: Acute and Postoperative Pain Management" ...
Breaking Medicine Technology:
(Date:10/12/2017)... ... October 12, 2017 , ... IsoComforter, Inc. ( https://isocomforter.com ), ... of an innovative new design of the shoulder pad. The shoulder pad provides ... while controlling your pain while using cold therapy. By utilizing ice and water that ...
(Date:10/12/2017)... ... October 12, 2017 , ... Information about the technology: ... develop to enable prevention of a major side effect of chemotherapy in children. ... pediatric patients. For cisplatin, hearing loss is FDA listed on-label as a dose ...
(Date:10/12/2017)... ... , ... Leading pediatric oncology experts at Children’s National Health System ... of the International Society of Paediatric Oncology (SIOP) Oct. 12-15. Chaired by ... Blood Disorders at Children’s National, and Stephen P. Hunger, M.D., Chief of the ...
(Date:10/12/2017)... ... October 12, 2017 , ... ... nation's first interactive health literacy software tool, and the Cancer Patient Education Network ... cancer patient education, today announce a new strategic alliance. , As CPEN’s ...
(Date:10/12/2017)... D.C. (PRWEB) , ... October 12, 2017 , ... ... Cal Dining at the University of California Berkeley, and other leading institutions in ... the buying power of institutions to change the way animals are raised for ...
Breaking Medicine News(10 mins):